Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
On Apr. 3, 2020, the University of Minnesota announced it had created the stateï¾’s fourth on-site testing facility…
On Apr. 3, 2020, UNMC aunched a groundbreaking mobile app for Apple Iphone to screen large groups of…
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
On Apr. 3, 2020, Montefiore Health System and Albert Einstein College of Medicine started treating very sick COVID-19…
On Apr. 3, 2020, OHSU announced that it had established an in-house COVID-19 testing lab that OHSU staff…
On Apr. 3, 2020, OHSU announced that Mary and Ryan Finley, moved by the heroic work of frontline…
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
On Apr. 2, 2020, Novartis announced plans to initiate a phase III clinical trial in collaboration with Incyte…
On Apr. 2, 2020, a University of Chicago team announced that it had mapped confirmed COVID-19 infections per…
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the U.S….
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
On Apr. 2, 2020, Emergent BioSolutions announced it has entered into a formal partnership with the U.S. government…
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsinï¾–Madison and the vaccine companies…
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
On Apr. 1, 2020, Adamis Pharma announced that its wholly owned drug outsourcing facility, US Compounding Inc. (USC),…
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinï¾’s direct inhibition of SARS-CoV-2, the novel…
On Apr. 1, 2020, Cantel Medical announced it has accelerated surgical earloop mask production by its HuFriedyGroup dental…